Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Psoriatic Arthritis Therapeutic Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com
  • USA - English


News provided by

RnR Market Research

Jul 09, 2015, 21:30 ET

Share this article

Share toX

Share this article

Share toX

Psoriatic Arthritis Therapeutic Pipeline Review H1 2015
Psoriatic Arthritis Therapeutic Pipeline Review H1 2015

Dallas, Texas (PRWEB) July 10, 2015 -- The report “Psoriatic Arthritis - Pipeline Review, H1 2015” provides comparative analysis on the therapeutic development for Psoriatic Arthritis. The report strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Complete report with TOC is available @ http://www.rnrmarketresearch.com/psoriatic-arthritis-pipeline-review-h1-2015-market-report.html .

The report also reviews key players involved in the therapeutic development for Psoriatic Arthritis and special features on late-stage and discontinued projects. Companies discussed in this Psoriatic Arthritis - Pipeline Review, H1 2015 report include AbbVie Inc., AbGenomics International, Inc., Alder Biopharmaceuticals Inc., Amgen Inc., Avesthagen Limited, Biocon Limited, Bristol-Myers Squibb Company, Celgene Corporation, Celltrion, Inc., Coherus BioSciences, Inc., Covagen AG, Eli Lilly and Company, Epirus Biopharmaceuticals, Inc., Genor BioPharma Co., Ltd., Inbiopro Solutions Pvt. Ltd., Innovent Biologics, Inc., Johnson & Johnson, Kineta, Inc., Mabion SA, Momenta Pharmaceuticals, Inc., Novartis AG, Oncobiologics, Inc., Panacea Biotec Limited, Pfizer Inc., Sandoz International GmbH, Swedish Orphan Biovitrum AB, Therapeutic Proteins International, LLC and UCB S.A.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Drug Profiles mentioned in this report are abatacept (recombinant), AbGn-168H, ABT-122, adalimumab biosimilar, anakinra (recombinant), apremilast, bimekizumab, brodalumab, clazakizumab, COVA-322, dalazatide, etanercept biosimilar, golimumab, golimumab biosimilar, guselkumab, IBI-303, IBPM-004AM, IBPM-005IX, infliximab biosimilar, INV-17, itolizumab, ixekizumab, Peptide to Inhibit CD44 for Rheumatoid and Psoriatic Arthritis, secukinumab and tofacitinib.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=394571 . (This is a premium report priced at US$2000 for a single user License.)

List of Tables
Number of Products under Development for Psoriatic Arthritis, H1 2015 12
Number of Products under Development for Psoriatic Arthritis - Comparative Analysis, H1 2015 13
Number of Products under Development by Companies, H1 2015 15
Number of Products under Development by Companies, H1 2015 (Contd..1) 16
Number of Products under Development by Companies, H1 2015 (Contd..2) 17
Number of Products under Investigation by Universities/Institutes, H1 2015 18
Comparative Analysis by Late Stage Development, H1 2015 19
Comparative Analysis by Clinical Stage Development, H1 2015 20
Comparative Analysis by Early Stage Development, H1 2015 21
Comparative Analysis by Unknown Stage Development, H1 2015 22
Products under Development by Companies, H1 2015 23
Products under Development by Companies, H1 2015 (Contd..1) 24
Products under Development by Companies, H1 2015 (Contd..2) 25
Products under Investigation by Universities/Institutes, H1 2015 26
Psoriatic Arthritis - Pipeline by AbbVie Inc., H1 2015 27
Psoriatic Arthritis - Pipeline by AbGenomics International, Inc., H1 2015 28
Psoriatic Arthritis - Pipeline by Alder Biopharmaceuticals Inc., H1 2015 29
Psoriatic Arthritis - Pipeline by Amgen Inc., H1 2015 30
Psoriatic Arthritis - Pipeline by Avesthagen Limited, H1 2015 31
Psoriatic Arthritis - Pipeline by Biocon Limited, H1 2015 32
Psoriatic Arthritis - Pipeline by Bristol-Myers Squibb Company, H1 2015 33
Psoriatic Arthritis - Pipeline by Celgene Corporation, H1 2015 34
Psoriatic Arthritis - Pipeline by Celltrion, Inc., H1 2015 35
Psoriatic Arthritis - Pipeline by Coherus BioSciences, Inc., H1 2015 36
Psoriatic Arthritis - Pipeline by Covagen AG, H1 2015 37
Psoriatic Arthritis - Pipeline by Eli Lilly and Company, H1 2015 38
Psoriatic Arthritis - Pipeline by Epirus Biopharmaceuticals, Inc., H1 2015 39
Psoriatic Arthritis - Pipeline by Genor BioPharma Co., Ltd., H1 2015 40
Psoriatic Arthritis - Pipeline by Inbiopro Solutions Pvt. Ltd., H1 2015 41
Psoriatic Arthritis - Pipeline by Innovent Biologics, Inc., H1 2015 42
Psoriatic Arthritis - Pipeline by Johnson & Johnson, H1 2015 43
Psoriatic Arthritis - Pipeline by Kineta, Inc., H1 2015 44
Psoriatic Arthritis - Pipeline by Mabion SA, H1 2015 45
Psoriatic Arthritis - Pipeline by Momenta Pharmaceuticals, Inc., H1 2015 46
Psoriatic Arthritis - Pipeline by Novartis AG, H1 2015 47
Psoriatic Arthritis - Pipeline by Oncobiologics, Inc., H1 2015 48
Psoriatic Arthritis - Pipeline by Panacea Biotec Limited, H1 2015 49
Psoriatic Arthritis - Pipeline by Pfizer Inc., H1 2015 50
Psoriatic Arthritis - Pipeline by Sandoz International GmbH, H1 2015 51
Psoriatic Arthritis - Pipeline by Swedish Orphan Biovitrum AB, H1 2015 52
Psoriatic Arthritis - Pipeline by Therapeutic Proteins International, LLC, H1 2015 53
Psoriatic Arthritis - Pipeline by UCB S.A., H1 2015 54
Assessment by Monotherapy Products, H1 2015 55
Number of Products by Stage and Target, H1 2015 57
Number of Products by Stage and Mechanism of Action, H1 2015 59
Number of Products by Stage and Route of Administration, H1 2015 61
Number of Products by Stage and Molecule Type, H1 2015 63
Psoriatic Arthritis Therapeutics - Recent Pipeline Updates, H1 2015 129
Psoriatic Arthritis - Dormant Projects, H1 2015 179
Psoriatic Arthritis - Discontinued Products, H1 2015 180

List of Figures
Number of Products under Development for Psoriatic Arthritis, H1 2015 12
Number of Products under Development for Psoriatic Arthritis - Comparative Analysis, H1 2015 13
Number of Products under Development by Companies, H1 2015 14
Comparative Analysis by Late Stage Development, H1 2015 19
Comparative Analysis by Clinical Stage Development, H1 2015 20
Comparative Analysis by Early Stage Products, H1 2015 21
Assessment by Monotherapy Products, H1 2015 55
Number of Products by Top 10 Targets, H1 2015 56
Number of Products by Stage and Top 10 Targets, H1 2015 56
Number of Products by Top 10 Mechanism of Actions, H1 2015 58
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2015 58
Number of Products by Top 10 Routes of Administration, H1 2015 60
Number of Products by Stage and Top 10 Routes of Administration, H1 2015 61
Number of Products by Top 10 Molecule Types, H1 2015 62
Number of Products by Stage and Top 10 Molecule Types, H1 2015 63

Explore more reports on Arthritis therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/arthritis-therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Ritesh Tiwari, RnR Market Research, http://www.rnrmarketresearch.com/, +1 (888) 391-5441, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.